| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000045533 |
| Receipt No. | R000051986 |
| Scientific Title | An international, cluster randomised-sequence study of a safe-anastomosis quality improvement intervention to reduce anastomotic leak following right colectomy and ileocaecal resection |
| Date of disclosure of the study information | 2021/11/01 |
| Last modified on | 2022/11/06 (Ver. 2) |
| Basic information | ||||||||
| Public title | An international, cluster randomised-sequence study of a safe-anastomosis quality improvement intervention to reduce anastomotic leak following right colectomy and ileocaecal resection | |||||||
| Acronym | EAGLE | |||||||
| Scientific Title | An international, cluster randomised-sequence study of a safe-anastomosis quality improvement intervention to reduce anastomotic leak following right colectomy and ileocaecal resection | |||||||
| Scientific Title:Acronym | EAGLE | |||||||
| Region |
|
|||||||
| Condition | |||||
| Condition | All adult patients (age 18 years and above) undergoing right colectomy with or without primary anastomosis | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Malignancy | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | Cohort data suggest that anastomotic leak occurs after 8% of right colectomies causing significant morbidity and mortality. Patient selection, intra-operative factors, and technical variation all contribute to risk of leak. The EAGLE study will assess whether implementation of the European Society of Coloproctology (ESCP) Safe Anastomosis Intervention reduces anastomotic leak following right colectomy |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Anastomotic leak rate following right colectomy at 30-days after surgery |
| Key secondary outcomes | Clinical outcomes within 30-days of surgery including:
a. Reoperation for anastomotic leak b. Reoperation for any cause c. Unplanned admission to critical care d. Readmission to hospital e. Postoperative mortality f. Length of hospital stay |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Single blind -participants are blinded |
| Control | No treatment |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | ESCP Safe Anastomosis quality improvement intervention | |
| Interventions/Control_2 | Pre-intervention data will act as control data | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Inclusion criteria
Adults >=18 years of age. Right colectomy, defined as any colonic transection with the distal resection margin proximal to the splenic flexure. Procedures for any pathology (benign or malignant), via any operative approach (open, laparoscopic, robotic or converted). Patients undergoing elective (during a planned admission), expedited or emergency surgery (during an unplanned admission). Patients undergoing colectomy and a synchronous procedure on a different organ e.g. hepatic metastatectomy. |
|||
| Key exclusion criteria | Exclusion criteria
Patients undergoing more than one gastrointestinal anastomosis during the index operation. In Crohn's disease, additional upstream strictureplasty or resection/anastomosis to treat disease or strictures at the same operation. Patients undergoing concurrent hyperthermic intraperitoneal chemotherapy (HIPEC) and/or cytoreductive surgery. Individual patients should only be included in EAGLE once. Following the index EAGLE study procedure, patients undergoing further operative treatment within the study window should not have repeated entries created. |
|||
| Target sample size | 4400 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Fujita Health University Bantane Hospital | ||||||
| Division name | Department of Gastroenterological Surgery | ||||||
| Zip code | 454-8509 | ||||||
| Address | 3-6-10 Otoubashi, Nakagawa-ku, Nagoya City, Aichi, 454-8509, Japan | ||||||
| TEL | 052-321-8171 | ||||||
| akihori@fujita-hu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Fujita Health University Bantane Hospital | ||||||
| Division name | Department of Gastroenterological Surgery | ||||||
| Zip code | 454-8509 | ||||||
| Address | 3-6-10 Otoubashi, Nakagawa-ku, Nagoya City, Aichi, 454-8509, Japan | ||||||
| TEL | 052-321-8171 | ||||||
| Homepage URL | |||||||
| akihori@fujita-hu.ac.jp | |||||||
| Sponsor | |
| Institute | Fujita Health University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Fujita Health University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | University of Birmingham |
| Name of secondary funder(s) | the European Society of Coloproctology (ESCP) |
| IRB Contact (For public release) | |
| Organization | Fujita Health University Bantane Hospital |
| Address | 3-6-10 Otoubashi, Nakagawa-ku, Nagoya City, Aichi, 454-8509, Japan |
| Tel | 052-321-8171 |
| akihori@fujita-hu.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000051986 |